-
Diagnosis and Testing
-
False Negatives: Parvovirus tests can yield false negatives if the animal is not shedding the virus or if testing is performed too late. Always consider clinical signs alongside test results.
-
Concurrent Risks: Puppies at risk for parvovirus enteritis are also susceptible to intussusception and foreign bodies. Early imaging is recommended to rule out these conditions.
-
Monitoring During Hospitalization
-
Intussusception Vigilance: Even improving parvovirus patients can develop intussusception. Sudden vomiting in a recovering patient warrants immediate abdominal evaluation.
-
Gastrointestinal Obstructions: Regularly assess for signs of GI obstructions, as puppies may ingest foreign objects.
-
Treatment Strategies
-
Supportive Care:
-
Fluid Therapy: Use isotonic balanced crystalloid solutions to treat shock and rehydrate.
-
Antiemetics: Administer medications like metoclopramide, ondansetron, or maropitant citrate to control nausea and vomiting. Multiple agents may be used concurrently.
-
Antibiotic Use:
-
High-Risk Patients: Use antibiotics due to the risk of sepsis and bacteremia. Cefotaxime is preferred for broader gram-negative coverage.
-
Alternative Regimens: Enrofloxacin combined with ampicillin or metronidazole can be used cautiously, considering potential effects on young dogs.
-
Non-Septic Cases: A first-generation cephalosporin may suffice for patients without clinical signs of sepsis.
-
Nutritional Support:
-
Early Feeding: Begin micro-enteral nutrition with glucose and electrolytes within 12 hrs of hospitalisation.
-
Nasogastric Tube: Place a nasogastric feeding tube to decompress the stomach and to facilitate early nutritional support with micro-enteral and elemental or hydrolyzed diets.
-
Avoid Force-Feeding: Do not force-feed to prevent food aversions and stress.
-
Plasma Transfusions:
-
Early Administration: Consider giving fresh frozen plasma transfusion early to increase serum albumin and provide passive immunity.
-
Benefits: Early intervention may be more effective before severe protein loss occurs.
-
Adjunct Therapies:
-
Interferon: May be beneficial but is expensive and not universally available.
-
Monoclonal Antibodies: Can reduce severity and improve survival but may be cost-prohibitive.
-
Fecal Transplantation: Potentially aids in restoring gut microbiome in persistent diarrhea cases.Use in healthy recovering patients
-
Probiotics: Useful during recovery to re-establish healthy gut flora once the patient is eating and diarrhea has ceased.
-
Outpatient Management Options
-
When Hospitalization Isn’t Feasible: For clients unable to afford inpatient care, an outpatient protocol can be considered.
-
Treatment Components: Long-acting antibiotic (e.g., cefovecin), subcutaneous fluids, and maropitant.
-
Efficacy: Studies show about an 82% survival rate with this approach.
-
Limitations: Not suitable for all cases; close monitoring remains crucial.
-
General Recommendations
-
Early Detection: Prompt recognition and treatment of parvovirus enteritis improve outcomes.
-
Holistic Monitoring: Always be vigilant for secondary complications such as sepsis, GI obstructions, or intussusception.
-
Client Communication: Discuss all available treatment options, including costs and prognosis, to help clients make informed decisions.
-
Avoid Unnecessary Interventions: Granulocyte colony-stimulating factors are not beneficial and should be avoided.
-
Conclusion and Continuing Education
-
Stay Informed: Keep up with the latest research and treatment protocols to provide the best patient care.
-
Collaborate and Share Knowledge: Engage in professional discussions and conferences to enhance understanding and application of veterinary advancements.
A Deep Dive into Canine Parvoviral Enteritis